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A B S T R A C T
Objective: To evaluate the efﬁcacy and safety of the ketogenic diet (KD) treatment of refractory childhood
epilepsy in China and determine which children are more likely to respond.
Methods: Between 2004 and 2011, we prospectively enrolled 317 children with refractory epilepsy for
the KD treatment in Shenzhen Children’s Hospital and followed up for at least a year. Outcome was
measured by seizure frequencies before and after the diet, change in anticonvulsant use and adverse
effects. We also evaluated inﬂuences of different variables (starting age, duration of epilepsy and
underlying conditions) on the outcome.
Results: Intent-to-treat analysis showed that after 3, 6 and 12 months, 62.8%, 42.0% and 24.3% remained
on the diet, 35.0%, 26.2% and 18.6% showed >50% seizure reduction, including 20.8%, 13.6% and 10.7%
seizure free, respectively. Starting age may inﬂuence efﬁcacy. The 10 age group showed worse response
than the <10 age group, though the difference was statistically signiﬁcant (p = 0.039) at 3 month only.
Other variables such as duration of epilepsy at the start of the diet, seizure types and aetiologies showed
no signiﬁcant inﬂuence on efﬁcacy. Frequently reported complications included GI disturbance, food
refusal and hypoproteinaemia.
Conclusions: The KD is a safe and efﬁcacious therapy for intractable childhood epilepsy in Chinese
children. The inﬂuence of age on efﬁcacy is worth further investigation.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Despite recent development of anticonvulsants, 20–30% of
childhood epilepsies are medically refractory.1 The resurgence of
the ketogenic diet (KD), a high-fat, adequate-protein and low-
carbohydrate diet, has offered new hope to children with difﬁcult-
to-control epilepsy. This ﬁeld has generated much research
interest in the last twenty years, and the recent development
was summarised in Kessler et al.2 Currently, the KD has been
carried out in many different countries. Despite the perceived
difﬁculty of acceptance because of starch-based Asian diet, the KD
has been introduced in China as well. However, the only existing
study3 on the efﬁcacy of the KD in China was an early-stage
preliminary evaluation conducted on a small patient group in
Shenzhen Children’s Hospital.
Shenzhen Children’s Hospital is the ﬁrst institution in China to
implement a KD programme and the one with the most KD* Corresponding author at: Department of Paediatric Neurology, Shenzhen
Children’s Hospital, 7019 Yitian Road, Futian District, Shenzhen, Guangdong
518035, China. Tel.: +86 755 83936150; fax: +86 755 83936132.
E-mail address: epilepsycenter@vip.163.com (J. Liao).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.11.014patients to our knowledge. We believe this is a valuable therapy to
offer to children in China and therefore implemented its use in
2004. This report analyses 7 years’ clinical data to assess the
efﬁcacy and safety of the KD for Chinese children, and whether
response to the KD differs according to starting age, duration of
epilepsy, and disease classiﬁcation.
2. Methods
2.1. Patient selection
Between October 2004 and August 2011, 317 consecutive
patients started the KD in Shenzhen Children’s Hospital. They were
children with intractable epilepsy, who had tried at least 3
anticonvulsants but still had more than 4 seizures per week.
Children with known metabolic disorders, or severe systemic
illnesses were excluded. We noted that there was a wide variation
in the geographical and economic backgrounds of the children.
2.2. The KD initiation
All children were encouraged to initiate the KD as inpatients for
at least one week. Among the 317 children, 304 were admitted asvier Ltd. All rights reserved.
Table 1
Retention rate and seizure outcomes at 3, 6 and 12 months after initiation of the KD.
3 month 6 months 12 months
Number Percentage Number Percentage Number Percentage
Seizure free 66 20.8% 43 13.6% 34 10.7%
Reduction
90–99%
9 2.8% 11 3.5% 10 3.2%
Reduction
50–90%
36 11.4% 29 9.1% 15 4.7%
Reduction
<50%
25 7.9% 18 5.7% 6 1.9%
No change 63 19.9% 32 10.1% 12 3.8%
Retention 199 62.8% 133 42.0% 77 24.3%
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the ﬁrst week. During the inpatient period, parents were educated
on the rationale of the diet and ways to prepare the KD at home.
The remaining 13 children started the KD as outpatients. All
children were treated with the Johns Hopkins Hospital protocol4
with an initial fasting stage of about 24 h, and a diet lipid-to-non-
lipid ratio of 4:1. Every child was provided an average energy
intake of 60–80 kcal/kg per day, with 1–1.5 g/kg of protein
supplemented with potassium citrate, multi-vitamins and essen-
tial minerals.
The ﬁrst 30 children, starting between October 2004 and June
2007, had self-prepared meals planned according to the Ketogenic
Diet Meal Planner (designed by Liao using Chinese recipes). The
next 28, starting between September 2007 and September 2008,
used predominantly KetoCal (Nutricia) ketogenic formula as part
of their diet. To increase the palatability and variety of the diet,
Qitong ketogenic liquid milk (Zeneca), Qitong ketogenic cookies
(Zeneca) and packaged ketogenic set-meals (Zeneca) were devel-
oped by Liao, and added in as supplements to the Ketogenic Diet
Meal Planner since October 2008. All three Zeneca products have a
lipid-to-non-lipid ratio of 4:1, with 60% of the total lipid long-chain
triglyceride (LCT) and 40% medium-chain triglyceride (MCT).
All children were recommended to use the KD products such as
KetoCal (Nutricia), Qitong ketogenic liquid milk (Zeneca), Qitong
ketogenic cookies (Zeneca) and packaged ketogenic set-meals
(Zeneca) during the diet initiation stage, so as to achieve a stable
blood ketone level before switching to more ﬂexible self-prepared
food. The anticonvulsants were maintained unchanged for the ﬁrst
3 months of the diet and adjusted according to children’s
conditions afterwards.
2.3. Follow-up
Children were followed up at 1, 3, 6 and 12 months after the KD
initiation. They were either brought back to outpatient clinics or
contacted by phone calls. Seizure frequencies, adverse effects and
compliance with the diet were recorded. Height, weight, blood
tests, renal ultrasound (optional) and EEG (optional) were done
either in Shenzhen Children’s Hospital or at local hospitals based
on the Recommendations of the International Ketogenic Diet Study
Group.5 However, 18 children were lost to follow-up; their
outcomes were assessed by the records at the time of their last
contact and they were regarded as having stopped the diet after the
last contact.
The main measure of efﬁcacy was the decrease in seizure
frequency as assessed through parental report and seizure diaries.
The average seizure number in one month before a timepoint was
compared to the baseline seizure number (i.e. average seizure
number in the month before the start of the diet), and expressed as
a percentage of reduction. The seizure control was categorised intoTable 2
Comparison of efﬁcacy of the KD by different ages or duration of epilepsy at the start 
Age starting the KD 
<10 years 10 years p
3 months
Responderb 109 2 0
Non-responder 190 16 
6 months
Responder 81 2 0
Non-responder 218 16 
12 months
Responder 57 2 0
Non-responder 242 16 
a 15 cases with no duration of epilepsy data are excluded from analysis.
b Here and afterwards, responders refer to patients with at least 50% reduction in sethe following categories: (1) no change or increase in seizure
frequency, (2) <50% seizure reduction, (3) 50–90% seizure
reduction, (4) >90% seizure reduction, and (5) seizure free.
2.4. Statistical analysis
To evaluate the effect of age, duration of epilepsy, epilepsy
aetiology and seizure syndromes on the efﬁcacy of treatment, we
divided the cohort according to these variables and separately
analysed the efﬁcacy of the diet for each group. Classiﬁcations of
epilepsy aetiology and seizure syndromes were based on the 2001
ILAE report.6 We note that some terms, especially those used to
classify aetiologies, have since changed in the 2010 ILAE report.7
Statistical evaluation was performed using two-tailed Fisher
Exact Tests. A p-value less than 0.05 was regarded as statistically
signiﬁcant.
3. Results
3.1. Patient characteristics
Out of the 317 children, 206 were male and 111 were female.
The starting age of the KD ranged from 2 months to 17 years 8
months, with a mean of 39.6 months (standard deviation 37.1
months). The duration of the KD ranged from 1 day to 48 months,
with a mean of 5.7 months (standard deviation 7.0 months).
3.2. Treatment efﬁcacy
At 3 months after the initiation of the KD, 199 (62.8%) of the 317
children remained on the diet: 111 (35.0%) showed >50% seizure
reduction, and 66 (20.8%) were seizure free using an intent-to-treat
analysis (Table 1). At 6 months, 133 (42.0%) children remained on
the diet: 83 (26.2%) showed >50% seizure reduction, and 43
(13.6%) were seizure free. At 12 months, 77 (24.3%) childrenof the diet.
Duration of epilepsya
-Value <5 years 5 years p-Value
.0390 92 10 0.4584
173 27
.1725 69 8 0.6886
196 29
.5427 52 3 0.1115
213 34
izure frequency, the rest are non-responders.
Table 3
Efﬁcacy data at 12 months after the KD initiation according to different ages and duration of epilepsy at the start of the KD.
0–2 years (n = 147) 2–5 years (n = 102) 5–10 years (n = 50) 10 years (n = 18)
Outcome with regard to starting age
Seizure-free 17 (11.6%) 11 (10.8%) 5 (10.0%) 1 (5.6%)
Reduction 90–99% 3 (2.0%) 4 (3.9%) 3 (6.0%) 0 (0.0%)
Reduction 50–90% 7 (4.8%) 5 (4.9%) 2 (4.0%) 1 (5.6%)
Reduction <50% 2 (1.4%) 1 (1.0%) 2 (4.0%) 1 (5.6%)
No change 4 (2.7%) 4 (3.9%) 3 (6.0%) 1 (5.6%)
Retention 33 (22.4%) 25 (24.5%) 15 (30.0%) 4 (22.2%)
0–1 years (n = 113) 1–2 years (n = 73) 2–5 years (n = 79) 5 years (n = 37)
Outcome with regard to duration of epilepsy
Seizure-free 14 (12.4%) 10 (13.7%) 7 (8.9%) 1 (2.7%)
Reduction 90–99% 1 (0.9%) 1 (1.4%) 6 (7.6%) 1 (2.7%)
Reduction 50–90% 6 (5.3%) 5 (6.8%) 2 (2.5%) 1 (2.7%)
Reduction <50% 1 (0.9%) 1 (1.4%) 0 (0.0%) 3 (8.1%)
No change 2 (1.8%) 3 (4.1%) 4 (5.1%) 3 (8.1%)
Retention 24 (21.2%) 20 (27.4%) 19 (24.1%) 9 (24.3%)
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and 34 (10.7%) were seizure free.
Out of the 77 children who remained on the diet at 12 months,
27 achieved reduction of the number of anticonvulsants used,
including 15 who discontinued all drugs. Twenty-seven of these 77
children had a positive effect on development and behaviour, as
reported by the parents, including 6 children for whom seizure
control was not optimal i.e. <50% seizure reduction.
3.2.1. Effect of starting age and duration of epilepsy on diet efﬁcacy
We also compared the seizure outcomes at 3 months on the KD
according to age at the start of the diet, and found that children
more than 10 years old showed statistically worse (p < 0.05)
response to the KD than the rest of the children (Table 2). However,
this distinction became less signiﬁcant at 6 months and 12 months
into the diet. Duration of epilepsy at the start of the diet was not a
statistically signiﬁcant factor inﬂuencing children’s response to the
diet (Table 2). The detailed 12-month efﬁcacy statistics for children
of different starting ages and duration of epilepsy are presented in
Table 3.
3.2.2. Effect of aetiology and seizure types on diet efﬁcacy
For children with idiopathic epilepsy, 41.7% remained on the
diet at 12 months and 33.3% showed >50% seizure reduction,
compared to 24.2% and 18.0% respectively for children with
cryptogenic aetiology, and 22.9% and 18.1% for children with
symptomatic aetiology. Although a higher percentage of children
with idiopathic epilepsy had good seizure control, it was not
statistically different from the rest (p = 0.2465), possibly due to the
small number of children in this group. Children with infantile
spasms (IS), Lennox–Gastaut Syndrome (LGS) and tuberous
sclerosis (TS) behaved similarly to the whole group in terms of
retention rate and seizure outcomes, and there was no statistically
signiﬁcant difference according to seizure types (p = 0.2497 for IS,
p = 1 for LGS, p = 1 for TS, see Table 4). None of the DS children
remained on the diet at 12 months. However, due to small sampleTable 4
Retention rate and seizure outcomes at 12 months after the KD initiation according to
Overall Idiopathic Cryptogenic Sy
Cases 317 12 161 1
Seizure-free 34 (10.7%) 1 (8.3%) 19 (11.8%) 
Reduction 90–99% 10 (3.2%) 2 (16.7%) 4 (2.5%) 
Reduction 50–90% 15 (4.7%) 1 (8.3%) 6 (3.7%) 
Reduction <50% 6 (1.9%) 1 (8.3%) 4 (2.5%) 
No change 12 (3.8%) 0 (0%) 6 (3.7%) 
Retention 77 (24.3%) 5 (41.7%) 39 (24.2%) size in this population, the difference was inconclusive
(p = 0.3557).
3.2.3. Vertical comparison of diet efﬁcacy in Shenzhen Children’s
Hospital
According to diet composition, the 317 patients can be divided
into three groups: the ﬁrst 30 patients treated between 2004 and
2007 using meals prepared with the KD Meal Planner, next 28
patients treated between 2007 and 2008 using KetoCal, and the
remaining 259 patients using Qitong KD products. Patient
retention and efﬁcacy are summarised in Table 5.
3.3. Tolerability and adverse effects of the KD
Common adverse effects experienced by children included food
refusal, gastrointestinal disturbance and hypoproteinaemia
(Fig. 1). Gastrointestinal disturbance, including vomiting, diar-
rhoea and constipation, typically occurred within the ﬁrst week of
diet initiation. On the other hand, hypoproteinaemia mostly
appeared two weeks after the start of the KD.
Thirty-nine (12.3%) children experienced hypoproteinaemia.
Except one 12-year-old case, all hypoproteinaemia cases were
found in children below 5 years. Food refusal was often reported
by parents to precede hypoproteinaemia. There was no
statistical association between children’s starting weight-for-
age percentile (calculated according to Li et al.8) and their
likelihood of experiencing hypoproteinaemia. For children with
hypoproteinaemia, lipid-to-non-lipid ratio of the diet was
lowered to increase protein intake, and severe cases were
successfully controlled with intravenous infusion of albumin.
There were still 9 children who discontinued the diet due to
hypoproteinaemia.
Seven children had renal stones, among which 4 discontinued
the diet due to this complication. Three children had thrombocy-
topenia, and 2 out of 3 withdrew from the diet, platelet count
returned to normal after 2 weeks in the third child. different aetiologies and seizure types.
mptomatic IS LGS DS TS
44 157 39 7 7
14 (9.7%) 18 (11.5%) 4 (10.3%) – 1 (14.3%)
4 (2.8%) 2 (1.3%) 2 (5.1%) – 0 (0%)
8 (5.6%) 5 (3.2%) 1 (2.6%) – 0 (0%)
1 (0.7%) 2 (1.3%) 2 (5.1%) – 0 (0%)
6 (4.2%) 7 (4.5%) 2 (5.1%) – 0 (0%)
33 (22.9%) 34 (21.7%) 11 (28.2%) 0 (0%) 1 (14.3%)
Table 5
Patient retention and efﬁcacy data for patients using Ketogenic Diet Meal Planner, KetoCal and Qitong products.
3 months retention 12 months retention 3 months responders 12 months responders
Count Percentage Count Percentage Count Percentage Count Percentage
Meal planner group 19 63.3% 4 13.3% 7 23.3% 4 13.3%
KetoCal group 12 42.9% 6 21.4% 6 21.4% 6 21.4%
Qitong group 168 64.9% 67 25.9% 98 37.8% 49 18.9%
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withdrawn from the KD for more than 6 months before death, 2
died of status epilepticus, 2 died of pneumonia, 1 fell from height,
and for the remaining 2 cases, parents were unwilling to disclose
the cause of death.
3.4. Reasons for withdrawal
A total of 158 children reported their reasons of withdrawal.
More than one reason might be cited. Among these, the main
reason for diet discontinuation was limited efﬁcacy (46.2%). Other
top reasons included food refusal (39.2%) adverse effects (22.8%),
parents’ difﬁculty to continue (7.0%), incurrent illness (6.3%). In
addition, 7 children (4.4%) stopped within 12 months, although
they were seizure-free, due to parents’ concern of the cost or fear of
long-term side effects. These children all had stopped anticonvul-
sant use when they discontinued the diet and remained seizure-
free in the most recent follow-up.
4. Discussion
This study is the ﬁrst study evaluating the use of the KD in
Chinese children with refractory epilepsy. At 12 months after the
KD initiation, 18.6% of the children achieved >50% seizure
reduction, and 10.7% were seizure free. Other studies had a range
of 20–50% for patients with >50% seizure reduction, and a range of
4.8–25% for seizure free cases.4,9–11. Our results were comparable
but towards the lower end of the range. This was possibly caused
by the low retention rate. Out of the 317 children, 118 stopped the
KD before 3 months, among which 31 stopped before 2 weeks,
despite recommendation to the parents that the KD should be
maintained for at least 3 months in order to conﬁrm its efﬁcacy.
Families withdrew from the diet for various reasons. Limited
efﬁcacy was the most common, reason similar to other reports.9,12
However, a signiﬁcant proportion of our children discontinued the
diet due to intolerance. As the Chinese diet is heavily starch-based,
it was expected that Chinese children would ﬁnd it difﬁcult toFig. 1. Adverse effects of the KD, rankedaccept such a high-lipid diet. In addition, parents also reported
difﬁculties in diet preparation such as incorporating the KD into
Chinese recipes and relative inaccessibility to high-lipid, low-
carbohydrate food like butter and cream. A lot of effort has been
put in to improve the tolerability of the diet. This includes the
development of Chinese recipe-based Ketogenic Diet Meal Planner,
Qitong ketogenic liquid milk (Zeneca), Qitong ketogenic cookies
(Zeneca) and packaged ketogenic set-meals (Zeneca). As seen in
Table 5, 3 and 12-month retention/response rate generally
improved since switching to Qitong. However, signiﬁcant pro-
blems with tolerance of the diet still exist. Other factors such as
geographical inconvenience and economic difﬁculties also con-
tributed to the low retention rate; many children lived several
thousand kilometres away from our KD centre and the ﬁnancial
situation of different families varies. The recent establishment of
additional centres throughout China may improve the ability to
provide the diet effectively and increase the retention rate.
Similar to results from previous reports,13–19 our study showed
that the KD is beneﬁcial in seizure control for IS, LGS and TS. As in
Freeman et al.,4 Kang et al.,10 and DiMario et al.,20 no statistically
signiﬁcant differences in efﬁcacies were found among groups of
different epilepsy syndromes or aetiologies. However, contrary to
Caraballo et al.,21 children with DS did not show favourable
response, though the difference was inconclusive and likely caused
by small group size. The small idiopathic group had a 12-month
responder percentage of 33.3% compared to the 18.0% in the
remaining children. Though statistically insigniﬁcant, the better
response among this small group suggests further study into this
population.
Starting age also had an effect on efﬁcacy, with children older
than 10 years having a worse response to the KD than younger
children, although the difference was signiﬁcant at 3 months only.
It has been observed in other studies that the KD may be more
effective in younger children 4,11, and several explanations have
been suggested. One possibility is that older children are less
tolerant of the diet. However, in our study, children above 10 years
old had 3-month, 6-month and 12-month retention rates of 61.1%, by occurring frequencies (n = 317).
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42.5% and 24.4% for children below 10. The second possible
explanation is that older children have had epilepsy for a longer
period of time and there are studies showing that diet was most
effective in those who had experienced seizures for the shortest
period of time.22 Hence we tested the inﬂuence of the duration of
epilepsy on the efﬁcacy of the diet. No statistically signiﬁcant
result was found, but the p-value of 0.112 in the 12-month
response (Table 2) suggests a link worth further investigation. The
third possible explanation is that younger children are better at
extracting ketones from the blood into the brain.23We were unable
to verify this claim using our clinical data.
Compared to other studies,24–26 a relatively high percentage
of our children experienced hypoproteinaemia. Parents’ reported
association between food refusal and hypoproteinaemia and the
fact that lowering lipid-to-non-lipid ratio alleviated the problem
suggested that hypoproteinaemia might be caused by food
refusal and insufﬁcient protein intake. Hypoproteinaemia was
predominantly observed among children below 5 years. Howev-
er, the lack of association between hypoproteinaemia and
starting weight percentile makes it difﬁcult for us to further
screen for susceptible patients among younger children. Aiming
to reduce hypoproteinaemia, we recently started a trial of using
2:1 lipid-to-non-lipid ratio.
Our reported rates of other adverse effects were comparable
to those of previous reports.4,25,27 Seven children died during
the diet. It is difﬁcult to judge whether the KD had contributed
to the deaths, and care should be taken in monitoring children
on the KD closely.
In conclusion, as the ﬁrst institution to have implemented the
KD programme in China, we observed that the KD is a safe and
efﬁcacious treatment option for refractory epilepsy in Chinese
children. The KD is shown to be effective in children with infantile
spasm, Lennox–Gastaut syndrome and tuberous sclerosis, and the
treatment efﬁcacy is better among children below 10 years.
However, as the Chinese diet has signiﬁcantly less fat and more
carbohydrate than Western ones, difﬁculties with diet mainte-
nance and food refusal were experienced. Future work is needed to
improve tolerability.
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